Boehringer Ingelheim Vetmedica Acquires Licensing Rights for Artilysin(R) Technology from Lysando AG

General Press Releases Wednesday August 13, 2014 14:56
REGENSBURG, Germany--(BUSINESS WIRE)--Aug. 12, 2014

Artilysin(R), a new and innovative technological approach in the fight against pathogenic and multi-resistant bacteria, developed by the research & development company Lysando, has arrived in the pharmaceutical industry. Boehringer Ingelheim Vetmedica has secured the licensing rights for the technology platform Artilysin(R). The company is hopeful to receive significant momentum and solutions from this new substance class for the problem of multi-resistant bacteria, which also is an increasing threat to the animal world.

Artilysin(R)s are proteins that, through a physical mechanism, selectively eliminate pathogenic, multi-resistant and persisting bacteria. By way of license, Boehringer Ingelheim Vetmedica is taking advantage of the possibilities presented by this technology. The scope of applications for Artilysin(R)s spans from human and animal medicine to the food industry and the area of hygiene. They work quickly and with their “friend or foe” identification very specifically and are completely biodegradable. Additionally, no resistances occurred during the expansive studies. Multi-resistant bacteria pose a significant threat to health due to the increasing ineffectiveness of antibiotics. The EU Commission estimates the annual number of deaths caused by multi-resistant bacteria at 25,000. Massive economic effects are linked to this fact.

The Boehringer Ingelheim Group is among the 20 leading pharmaceutical companies worldwide. Their focus areas include research & development, production and marketing of new medicines with significant therapeutic benefits for human and animal health. In 2013, Boehringer Ingelheim reported revenues of appr. 14.1 bn Euros.

Lysando itself is not a manufacturer of pharmaceutical products nor will it become one in the future; it only provides its new technology platform through licensing. "The acquisition of licensing rights for the Artilysin(R) technology by Boehringer Ingelheim Vetmedica is a decisive step in the acceptance of this new class of substances“, explains Markus Matuschka v. Greiffenclau, CEO of Lysando AG.

About Lysando:

Lysando AG is a technology leader in the area of antimicrobial proteins. Since its foundation in 2009, the privately financed research company has done research on artificial designer proteins with a team of scientists in the town of Regensburg. Artilysin(R)s represent a revolutionary breakthrough in the battle against multi-resistant bacteria. With this new technology platform, drugs and substances against pathogenic gram-negative and gram-positive bacteria can be specifically developed, both for antibiotic-resistant and persisting bacteria. With Artilysin(R)s, Lysando has created an effective alternative to antibiotics.

CONTACT:
Press Contact:
WBCO Public Relations & Business Communications GmbH
Frank Wollstein
Tel.: +49-(0)-69 / 133-880-36
Fax: +49-(0)-69 / 133-880-33
Email: f.woellstein@wbco.de

Latest Press Release

Asia-Pacific countries strengthen regional transport connectivity to drive sustainable development

Bangkok (ESCAP news) – Countries in the region today reinforced their commitment to implement the Regional Action Programme for Sustainable Transport Connectivity in Asia and the Pacific, Phase I (2017 – 2020). The Programme was adopted by...

Pattana Golf Club Resort won two awards at the 2018 SPIA Asia Awards Ceremony

Pattana Golf Club & Resort in Sriracha, Chonburi Province, Thailand won two awards at the 2018 SPIA Asia Awards Ceremony in Bangkok. Pattana Kids Triathlon received Silver Award (via our subsidiary C55 Events) for the Best Youth Sports Development...

Zoomlion to Reveal Designs for the Future at bauma China 2018 with 4.0 Intelligent Machinery

Zoomlion Heavy Industry Science & Technology Co., Ltd. (Zoomlion), China's top construction machinery manufacturer, will exhibit a comprehensive lineup of the brand's Generation 4.0 smart products at bauma China 2018, which will open on November 27...

Proya#s mission for its 15th anniversary: Let the world see Beauty of China

Proya (SHA: 603605), the No.1 cosmetics company on China's A-share market, held its 15th anniversary celebration themed "PROYA 15th Anniversary Gala Beautifying the Future" in Hangzhou on November 19. All-star guest lineup heralds the next chapter in...

Bring your family to celebrate Father#s Day at Furama Silom, Bangkok.

Celebrate Father's Day with our special international lunch buffet on 5 December 2018 from 11.45hrs – 14.00hrs at Rama Restaurant. Enjoy very special discount for 'Early Bird' for THB. 399 from THB. 499 / person indulge in a widespread of seafood,...

Related Topics